Connect with us

Life style

Dr. Shama inspires hope in battle against breast cancer

Published

on

Dr. Sharma Goonatillake Consultant Clinical Oncologist

Breast cancer is the most common cancer among women in Sri Lanka. Annually, out of approximately 37,000 newly diagnosed cancer patients nearly 27% are attributed to female breast cancer. In contrast male breast cancer is significantly rarer, observed at a ratio of about 1:100 compared to female cases.

On a daily basis, the statistics translate to approximately 15 new female breast cancer patients being detected with sadly three fatalities due to this disease. An excerpt from an interview with Dr Shama

Goonatilleke, Consultant Oncologist at Asiri Surgical Hospital

Breast cancer remains one of the most common cancers among women. What trends are you seeing locally in terms of age, risk and incidence?

Breast cancer is the most common cancer among women in Sri Lanka. Annually, out of approximately 37 000 newly diagnosed cancer patients, nearly 27% are attributed to female breast cancer. In contrast, male breast cancer is significantly rarer, observed at a ratio of about 1:100 compared to female cases.

On a daily basis, the statistics translate to approximately 15 new breast cancer patients being detected, with sadly, three fatalities due to this disease.

In Sri Lanka, the key trends for breast cancer show a significant increase in incidence, particularly affecting older, post-menopausal women, and a growing prevalence of lifestyle-related risk factors.

The age-standardized incidence rate for female breast cancer in Sri Lanka has shown a steady and significant increase over the years, rising from 18.4 per 100,000 in 2005 to 34.4 per 100,000 in 2019. A gradual increase of approximately 4% per year was observed between 2001 and 2010, with the trend expected to continue.

The highest incidence of breast cancer is observed in women aged 50 to 59 years, with the mean age of diagnosis around 56 years. The increase in incidence has been substantially greater among women older than 50 years compared to younger women. While the incidence is lower in younger age groups, cases are reported from the 20-24 age group onwards, and nearly one-third of cases are reported before the age of 50. A significant proportion of patients are diagnosed at advanced stages (Stage III and IV), which contributes to lower survival rates compared to developed countries.

Why are we witnessing more breast cancer cases in younger women today?

Unfortunately, breast cancer is not a preventable cancer. The rise in breast cancer cases among younger women today is attributed to a complex interplay of lifestyle changes, environmental exposures, hormonal/reproductive shifts, and genetic factors. No single cause fully explains the trend, and research is ongoing.

Lifestyle and Hormonal Factors: Reproductive Changes:

Women are having their first child later in life or not having children at all, and are less likely to breastfeed. Pregnancy and breastfeeding, especially at a younger age, have a protective effect against breast cancer later in life, and the loss of this protection increases risk.

Increased Lifetime Estrogen Exposure:

Girls are starting menstruation earlier and women are entering menopause later, increasing the number of menstrual cycles and the body’s lifetime exposure to estrogen and progesterone, which can fuel the growth of hormone-receptor-positive breast cancers.

Obesity and Weight Gain:

Higher rates of obesity and weight gain during childhood and adulthood are associated with increased inflammation and hormonal imbalances, raising the risk of breast cancer in premenopausal young women.

Alcohol Consumption:

Alcohol intake is clearly linked to an increased risk of breast cancer, and the risk increases with the amount consumed. Alcohol consumption among young Sri Lankan females have increased during recent past.

Physical Inactivity and Diet:

A lack of physical activity and diets high in red meat and processed foods, which are common in “Western-style” diets, are linked to an increased cancer risk.

Environmental Exposures:

Endocrine-Disrupting Chemicals:

The current generation of young women has grown up exposed to a wider array of chemicals than ever before, including endocrine disruptors in plastics (like BPA and phthalates), cosmetics, pesticides, and food packaging. These chemicals can mimic hormones and interfere with hormonal regulation, increasing susceptibility to cancer.

Air Pollution:

Exposure to air pollutants can be absorbed into breast tissue and contribute to cancer development.

Other Potential Factors:

Genetics: Younger women getting breast cancer are more likely to have a genetic predisposition, such as BRCA1 and BRCA2 gene mutations, some may be direcDr. Shama inspires hope in

battle against breast cancertly getting from their parents,are associated with higher cancer risk and more aggressive forms of the disease.

Increased Awareness and Screening:

While not a cause of the disease itself, recent changes to screening guidelines (such as the recommendation to start mammograms at age 40) lead to earlier detection of existing cancers, which may contribute to the uptick in reported cases in this age group.

Researchers emphasize that these factors likely interact with one another, and exposures during critical windows of susceptibility, such as puberty and pregnancy, may be particularly impactful.

What early warning signs should women be paying attention to?

Women should pay attention to any new or unusual changes in the look or feel of their breasts, chest, or armpit areas. The most common early warning sign of breast cancer is a new lump or thickening, but other symptoms can occur even without a lump.

A new lump or thickening in the breast or armpit area, which may be painless and have irregular edges (though some can be soft, round, or tender).

Changes in the size or shape of one or both breasts.

Skin changes on the breast, such as dimpling, puckering, redness, scaling, or irritation (sometimes described as resembling an orange peel texture).

Nipple changes, including a nipple that pulls inward (inverts), changes direction, or has a rash or scaling.

Nipple discharge (other than breast milk), especially if it is clear or bloody and happens spontaneously (without squeezing).

Persistent pain in the breast or nipple area that is new and does not go away after a menstrual cycle.

Swelling or a lump in the armpit or around the collarbone, as cancer can spread to nearby lymph nodes.

It is important to become familiar with the normal look and feel of your breasts through regular self-exams so that any changes can be spotted promptly. While many of these symptoms can be caused by benign (non-cancerous) conditions, any new and persistent changes should be evaluated by a healthcare professional as soon as possible for an accurate diagnosis. Early detection significantly improves the chances for effective treatment and positive outcomes.

Many women are still hesitant about breast screening. What misconceptions prevent early detection?

Misconceptions and fears that prevent women from attending breast screening and receiving an early diagnosis include false beliefs about personal risk, the screening procedure’s safety and comfort, and the outcomes of a cancer diagnosis

Key misconceptions preventing early detection are:

“I am not at risk because I am healthy/have no family history.” This is a very common myth. The truth is that most breast cancers occur in women with no family history, and healthy habits only reduce the risk, not eliminate it. A woman’s primary risk factors are simply being a woman and getting older.

“Mammograms are painful or dangerous.” Many women avoid screening due to fear of pain or concerns about radiation exposure. In reality, the procedure may cause brief, manageable discomfort, and the radiation dose is very low and considered safe by medical guidelines. The benefits of early detection far outweigh the minimal risks.

“Only women with symptoms or lumps need screening.” Mammograms are designed to find cancer years before physical symptoms, such as a lump, can be felt. Waiting for symptoms often means the cancer is more advanced and potentially less treatable.

“A painless lump is harmless.” Most breast cancers do not cause pain. Any new lump or unusual change should be checked by a healthcare provider regardless of whether it is painful.

“Breast cancer is a death sentence.” This fatalistic view can lead women to avoid screening or delay treatment. With early detection, the 5-year relative survival rate for localized breast cancer is an impressive 99%.

“Breast self-exams are enough.” While self-awareness of breast changes is important, self-exams alone are not a substitute for regular professional screenings like mammograms, which can detect much smaller cancers.

“Newer tests make mammograms obsolete.” While other tools like ultrasound and MRI are used for high-risk cases, mammography remains the gold standard and most effective tool for average-risk screening and early detection.

Other Barriers:

Fear and Anxiety:

Many women avoid screening due to fear of the results (receiving a cancer diagnosis) or the procedure itself.

Socio-cultural factors:

Taboos, stigma, or a preference for traditional medicine can lead to significant delays in seeking conventional care.

Logistical and financial issues

: Cost, lack of health insurance, difficulty accessing healthcare facilities (e.g., transportation issues), or an inability to take time off work or find childcare can all prevent women from attending appointments.

Lack of knowledge:

Low awareness of the benefits of screening, the risk factors, and the signs and symptoms of breast cancer contributes to hesitation and delay

Addressing these misconceptions through better education and communication from healthcare providers is essential to encouraging regular screening and improving outcomes.

How has modern technology improved breast cancer treatment outcome at Asiri AOI (American Oncology Centre) cancer centre?

Modern technology has improved breast cancer treatment outcomes at Asiri AOI Cancer Centre by enabling more accurate, personalized, and less invasive care, which enhances efficacy while minimizing side effects and recovery times.

Key technological advancements and their impact include:

Diagnosis and Staging

Advanced Imaging (PET-CT, MRI, 3D Mammography): These technologies allow for the detection of tumors at earlier stages and provide detailed information on their location, size, and extent. This precision in staging is crucial for developing the most effective treatment plans, which directly improves survival rates.

Genetic and Histopathology Labs: Asiri AOI uses advanced labs for genetic testing and biomarker analysis to understand cancer at a molecular level. This allows for the classification of breast cancer into specific subtypes (e.g., hormone receptor-positive, HER2-positive) and the development of personalized treatment plans tailored to the patient’s unique cancer profile, improving treatment efficacy and reducing unnecessary therapies.

Treatment Modalities Surgical Techniques

Sentinel Lymph Node Biopsy (SLNB): This minimally invasive procedure has largely replaced the traditional, more extensive axillary lymph node dissection. SLNB accurately stages the cancer while significantly reducing the risk of lymphedema and other post-surgical complications, leading to better recovery and quality of life.

Intraoperative Guidance:

Techniques such as image-guided surgery and the potential future use of cancer-targeted dyes or molecular probes during operations help surgeons ensure complete tumor removal while preserving maximum normal breast tissue, reducing the need for re-operations and improving cosmetic results.

Systemic Therapies

Targeted Therapy and Immunotherapy:

By using insights from advanced diagnostics, in addition to traditional chemotherapy clinicians can employ targeted therapies and immunotherapies that focus on specific cancer-driving molecules or leverage the body’s own immune system to fight cancer. These treatments are often more effective and have fewer side effects than traditional chemotherapy.

Precision Radiotherapy (TrueBeam STx)

Asiri AOI utilizes the TrueBeam STx radiotherapy system, which delivers high doses of radiation with sub-millimeter accuracy.

Improved outcomes:

This system targets cancer cells while sparing healthy surrounding tissues and organs (like the heart and lungs), which reduces side effects and long-term complications.

Efficiency:

It allows for faster treatment sessions and fewer visits (e.g., reducing multi-week radiation courses to a few sessions or even intraoperative radiotherapy options), which improves patient comfort and quality of life.

Overall, the integration of these modern technologies, combined with a multidisciplinary approach and adherence to international protocols (via collaboration with UPMC), enables Asiri AOI Cancer Centre to provide world-class, individualized care that has significantly improved breast cancer treatment outcomes.

Is radiotherapy recommended for every breast cancer patient? When is it more beneficial?

No, radiotherapy is not recommended for every breast cancer patient. The decision to use radiotherapy is personalized and based on a variety of factors related to the cancer’s characteristics, the type of surgery performed, and the patient’s overall health.

Radiotherapy is primarily used to destroy any remaining cancer cells after surgery and reduce the risk of the cancer coming back in the breast area or nearby lymph nodes. It is generally more beneficial, and often standard, in the following situations:

After Breast-Conserving Surgery (Lumpectomy): Radiotherapy to the remaining breast tissue is a standard part of treatment to lower the risk of local recurrence. Some very low-risk, older patients (e.g., age 70 or older with a small, hormone receptor-positive tumor) who are receiving hormone therapy may be able to skip it, but this is an exception.

After a Mastectomy:

It is often recommended if there is a high risk of the cancer returning to the chest wall or nearby lymph nodes. This includes cases where:

The tumor was large (larger than 5 cm).

Cancer has spread to the lymph nodes (especially four or more, but potentially even one to three).

Surgical margins have cancer cells (positive or very close margins).

The cancer has grown into the skin or muscles.

For Certain Aggressive Cancers: Radiotherapy is a key part of the treatment plan for inflammatory breast cancer.

For Advanced or Metastatic Cancer: It can be used as a palliative treatment to shrink tumors, relieve pain, and control symptoms when cancer has spread to other parts of the body, such as the bones or brain.

Before Surgery (Neoadjuvant therapy): In some cases, it can be used to shrink a large tumor to make it easier to remove with surgery.

A patient may not be an ideal candidate for radiotherapy in certain situations:

Very Early Stage, Low-Risk Breast Cancer: Some patients with early-stage, small, hormone receptor-positive tumors that have not spread to the lymph nodes may not require radiotherapy, especially if they are older and receiving hormone therapy.

Prior Radiation Exposure: Patients who have previously had radiation therapy to the same area (chest/breast) cannot typically receive a second course due to the risk of damage to healthy tissues.

Certain Medical Conditions:

Individuals with connective tissue diseases (like lupus or scleroderma) or severe heart/lung problems may face higher risks of complications.

Genetic Predisposition:

Patients with certain genetic mutations, such as Li-Fraumeni syndrome or some ATM mutations, may be advised against radiotherapy due to a higher risk of developing a second cancer later.

Pregnancy:

Radiotherapy is generally avoided during pregnancy.

Ultimately, the decision to use radiotherapy is made through a discussion between the patient and their healthcare team (including a radiation oncologist), weighing the benefits of reducing recurrence risk against potential side effects and the individual’s specific health factors.

Many patients initially fear diagnosis more than the disease. How do you help them cope emotionally?

Helping patients cope with the fear of a potential diagnosis involves compassionate communication, providing clear information, offering emotional support, and empowering them with a sense of control.

Compassionate and Empathetic Communication

Active Listening: Give the patient your undivided attention and allow them to express their fears, worries, and anxieties without interruption. Acknowledging their feelings with phrases like, “I understand why you’re feeling this way” or “It’s okay to feel scared,” helps them feel heard and validated.

Acknowledge and Normalize Feelings: Reassure patients that denial, fear, anxiety, and anger are normal responses to the stress and uncertainty of a potential serious diagnosis.

Be Aware of Non-Verbal Cues:

Use calm body language, maintain appropriate eye contact, and use a warm, comforting tone of voice to convey support and sincerity. A reassuring touch on the arm, when appropriate and consensual, can also make a difference.

Honesty and Transparency:

Be honest about what is known and what is unknown, as this builds trust. Avoid giving false reassurance or minimizing their concerns, as this can break trust and make them feel misunderstood.

Information and Education

Provide Clear, Simple Information: Explain medical conditions, tests, and procedures in clear, non-medical language to reduce the “fear of the unknown”. Use visual aids if helpful.

Encourage Questions: Create an open, non-judgmental environment where patients feel comfortable asking questions. Offer your contact details or a specific point of contact for follow-up questions they may have later.

Guide Information Seeking: Advise patients on reliable sources for information and gently discourage unhelpful internet searches, which can increase anxiety with misinformation.

Empowerment and Control

Involve Patients in Decision-Making: Discuss options and allow patients to be active participants in their care plans. This gives them a sense of control, which is often lost during a health crisis.

Focus on the Next Steps: Collaboratively formulate a plan for immediate next steps and contingencies. A clear action plan helps shift focus from worry to proactive management.

Set Realistic Goals: Help patients focus on manageable, day-to-day goals and activities, rather than overwhelming long-term expectations, to prevent feelings of frustration and failure.

Support Networks and Coping Strategies

Involve Family and Friends: With patient consent, involve loved ones in the conversation. They can offer emotional support and help remember information and instructions.

Suggest Coping Techniques: Introduce relaxation strategies such as deep breathing exercises, mindfulness, meditation, music therapy, art therapy, aroma therapy, or guided imagery.

Recommend Support Groups: Connect patients with peer support groups or online communities where they can talk to others who have similar diagnoses and experiences. Hearing personal stories can provide valuable perspective and coping strategies.

Refer to Mental Health Professionals: Encourage patients to seek professional help from a counselor or psychologist who specializes in health anxiety if their feelings become overwhelming or interfere with daily life and treatment adherence.

What lifestyle factors contribute to increased breast cancer risk – especially in urban areas?

Can diet exercise or hormone regulation reduce risk?

How can survivors, ensure long term health and reduce recurrence risk?

Breast cancer survivors can ensure long-term health and reduce recurrence risk through a combination of consistent medical follow-up, healthy lifestyle choices (diet, exercise, weight management), avoiding harmful habits, and managing emotional well-being.

Medical Follow-Up and Adherence to Treatment

Regular Check-ups and Screenings: Adhere strictly to your follow-up schedule with your oncology team or primary care physician. These visits, typically every few months initially and then annually after five years, are crucial for monitoring signs of recurrence or new cancers.

Annual Mammograms: Continue annual mammograms on the remaining breast tissue (or both if you had breast-conserving surgery).

Adherence to Therapies: If prescribed, complete the full course of hormone therapy (e.g., tamoxifen, aromatase inhibitors) or other maintenance therapies, as early discontinuation increases the risk of recurrence.

Discuss Advanced Therapies: Talk to your doctor about advanced therapy options, as modern targeted treatments can significantly reduce long-term risk for specific cancer types.

Know Your Body and Report Changes: Be vigilant for new or persistent symptoms, such as new lumps, unexplained pain, chronic cough, or sudden weight loss, and report them to your doctor immediately.

Healthy Lifestyle Choices

Maintain a Healthy Weight: Obesity is a significant risk factor for recurrence. Aim to achieve and maintain a healthy weight through diet and exercise.

Be Physically Active: Regular physical activity can reduce breast cancer mortality and recurrence risk by a significant percentage (up to 40%). Aim for at least 150-300 minutes of moderate-intensity aerobic exercise (like brisk walking) or 75-150 minutes of vigorous activity per week, plus two strength-training sessions per week.

Eat a Balanced Diet: Focus on a diet rich in a variety of colorful fruits, vegetables, whole grains, and lean proteins (fish, chicken, legumes). Limit red and processed meats, highly processed foods, and sugary drinks.

Avoid Alcohol: Avoid alcohol, as alcohol intake is linked to an increased risk of a second primary breast cancer.

Quit Smoking: Smoking increases the risk of recurrence and overall mortality. Seek support to quit immediately.

Consider Vitamin D: Low levels of vitamin D may be associated with a higher risk of recurrence. Discuss monitoring your levels and appropriate supplementation with your healthcare team, especially for bone health.

Emotional and Mental Well-Being

Manage Stress: Chronic stress can impact immune function. Utilize stress-reduction activities like yoga, meditation, gardening, or counseling to manage anxiety and the fear of recurrence.

Seek Support: Connect with friends, family, or support groups of other survivors. Sharing experiences and building a strong support network can improve quality of life and emotional health.

Prioritize Sleep: Aim for at least seven hours of quality sleep per night to aid physical and mental recovery.

By Zanita Careem



Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Life style

Salman Faiz leads with vision and legacy

Published

on

At the helm - blending heritage with vision

Salman Faiz has turned his family legacy into a modern sensory empire. Educated in London, he returned to Sri Lanka with a global perspective and a refined vision, transforming the family legacy into a modern sensory powerhouse blending flavours,colours and fragrances to craft immersive sensory experiences from elegant fine fragrances to natural essential oils and offering brand offerings in Sri Lanka. Growing up in a world perfumed with possibility, Aromatic Laboratories (Pvt) Limited founded by his father he has immersed himself from an early age in the delicate alchemy of fragrances, flavours and essential oils.

Salman Faiz did not step into Aromatic Laboratories Pvt ­Limited, he stepped into a world already alive with fragrance, precision and quiet ambition. Long before he became the Chairman of this large enterprise, founded by his father M. A. Faiz and uncle M.R. Mansoor his inheritance was being shaped in laboratories perfumed with possibility and in conversations that stretched from Colombo to outside the shores of Sri Lanka, where his father forged early international ties, with the world of fine fragrance.

Growing up amidst raw materials sourced from the world’s most respected fragrance houses, Salman Faiz absorbed the discipline of formulation and the poetry of aroma almost by instinct. When Salman stepped into the role of Chairman, he expanded the company’s scope from a trusted supplier into a fully integrated sensory solution provider. The scope of operations included manufacturing of flavours, fragrances, food colours and ingredients, essential oils and bespoke formulations including cosmetic ingredients. They are also leading supplier of premium fragrances for the cosmetic,personal care and wellness sectors Soon the business boomed, and the company strengthened its international sourcing, introduced contemporary product lines and extended its footprint beyond Sri Lanka’s borders.

Where raw materials transform into refined fragrance

Salman Faiz -carrying forward a legacy

Today, Aromatic Laboratories stands as a rare example of a second generation. Sri Lankan enterprise that has retained its soul while embracing scale and sophistication. Under Salman Faiz’s leadership, the company continues to honour his father’s founding philosophy that every scent and flavour carries a memory, or story,and a human touch. He imbibed his father’s policy that success was measured not by profit alone but the care taken in creation, the relationships matured with suppliers and the trust earned by clients.

“We are one of the leading companies manufacturing fragrances, dealing with imports,exports in Sri Lanka. We customise fragrances to suit specific applications. We also source our raw materials from leading French company Roberte’t in Grasse

Following his father, for Salman even in moments of challenge, he insisted on grace over haste, quality over conveniences and long term vision over immediate reward under Salman Faiz’s stewardship the business has evolved from a trusted family enterprise into a modern sensory powerhouse.

Now the company exports globally to France, Germany, the UK, the UAE, the Maldives and collaborates with several international perfumes and introduces contemporary products that reflect both sophistication and tradition.

We are one of the leading companies. We are one of the leading companies manufacturing fine and industrial fragrance in Sri Lanka. We customise fragrances to suit specific applications said Faiz

‘We also source our raw materials from renowned companies, in Germany, France, Dubai,Germany and many others.Our connection with Robertet, a leading French parfume House in Grasse, France runs deep, my father has been working closely with the iconic French company for years, laying the foundation for the partnership, We continue even today says Faiz”

Today this business stands as a rare example of second generation Sri Lankan entrepreneurship that retains its souls while embracing scale and modernity. Every aroma, every colour and every flavour is imbued with the care, discipline, and vision passed down from father to son – a living legacy perfected under Salmon Faiz’s guidance.

By Zanita Careem

Continue Reading

Life style

Home coming with a vision

Published

on

Uruwela Estate team

Harini and Chanaka cultivating change

When Harini and Chanaka Mallikarachchi returned to Sri Lanka after more than ten years in the United States, it wasn’t nostalgia alone that they brought home . It was purpose.Beneath the polished resumes and strong computer science backgrounds lay something far more personal- longing to reconnect with the land, and to give back to the country that shaped their memories. From that quiet but powerful decision was born Agri Vision not just an agricultural venture but a community driven movement grounded in sustainability ,empowerment and heritage. They transform agriculture through a software product developed by Avya Technologies (Pvt Limited) Combining global expertise with a deep love for their homeland, they created a pioneering platform that empowers local farmers and introduce innovative, sustainable solutions to the country’s agri sector.

After living for many years building lives and careers in theUnited States, Harini and Chanaka felt a powerful pull back to their roots. With impressive careers in the computer and IT sector, gaining global experience and expertise yet, despite their success abroad, their hearts remained tied to Sri Lanka – connection that inspired their return where they now channel their technological know-how to advance local agriculture.

For Harini and Chanaka, the visionaries behind Agri Vision are redefining sustainable agriculture in Sri Lanka. With a passion for innovation and community impact, they have built Agri Vision into a hub for advanced agri solutions, blending global expertise with local insight.

In Sri Lanka’s evolving agricultural landscape, where sustainability and authenticity are no longer optional but essential. Harini and Chanaka are shaping a vision that is both rooted and forward looking. In the heart of Lanka’s countryside, Uruwela estate Harini and Chanaka alongside the ever inspiring sister Malathi, the trio drives Agri Vision an initiative that fuses cutting edge technology with age old agricultural wisdom. At the core of their agri philosophy lies two carefully nurtured brands artisan tea and pure cinnamon, each reflecting a commitment to quality, heritage and people.

Armed with global exposure and professional backgrounds in the technology sector,they chose to channel thier experiences into agriculture, believing that true progress begins at home.

But the story of Agri Vision is as much about relationships as it is about technology. Harini with her sharp analytical mind, ensures the operations runs seamlessly Chanaka, the strategist looks outward, connecting Agri Vision to globally best practices and Malathi is their wind behind the wings, ensures every project maintains a personal community focussed ethos. They cultivate hope, opportunity and a blueprint for a future where agriculture serves both the land and the people who depend on it .

For the trio, agriculture is not merely about cultivation, it is about connection. It is about understanding the rhythm of the land, respecting generations of farming knowledge, and that growth is shared by the communities that sustain it. This belief forms the backbone of Agro’s vision, one that places communities not only on the periphery, but at the very heart of every endeavour.

Artisan tea is a celebration of craft and origin sourced from selected growing regions and produced with meticulous attention to detail, the tea embodier purity, traceability and refinement, each leaf is carefully handled to preserve character and flavour, reflecting Sri Lanka’s enduring legacy as a world class tea origin while appealing to a new generation of conscious consumers complementing this is pure Cinnamon, a tribute to authentic Ceylon, Cinnamon. In a market saturated with substitutes, Agri vision’s commitment to genuine sourcing and ethical processing stands firm.

By working closely with cinnamon growers and adhering to traditional harvesting methods, the brands safeguards both quality and cultural heritage.

What truly distinguishes Harini and Chanake’s Agri Vision is their community approach. By building long term partnerships with smallholders. Farmers, the company ensures fair practises, skill development and sustainable livelihoods, These relationships foster trust and resilience, creating an ecosystem where farmers are valued stakeholders in the journey, not just suppliers.

Agri vision integrates sustainable practices and global quality standards without compromising authenticity. This harmony allows Artisan Tea and Pure Cinnamon to resonate beyond borders, carrying with them stories of land, people and purpose.

As the brands continue to grow Harini and Chanaka remain anchored in their founding belief that success of agriculture is by the strength of the communities nurtured along the way. In every leaf of tea and every quill of cinnamon lies a simple yet powerful vision – Agriculture with communities at heart.

By Zanita Careem

Continue Reading

Life style

Marriot new GM Suranga

Published

on

Suranga new G. M. at Mariott

Courtyard by Marriott Colombo has welcomed Suranga Peelikumbura as its new General Manager, ushering in a chapter defined by vision, warmth, and global sophistication.

Suranga’s story is one of both breadth and depth. Over two decades, he has carried the Marriott spirit across continents, from the shimmering luxury of The Ritz-Carlton in Doha to the refined hospitality of Ireland, and most recently to the helm of Resplendent Ceylon as Vice President of Operations. His journey reflects not only international mastery but also a devotion to Sri Lanka’s own hospitality narrative.

What distinguishes Suranga is not simply his credentials but the philosophy that guides him. “Relationships come first, whether with our associates, guests, partners, or vendors. Business may follow, but it is the strength of these connections that defines us.” It is this belief, rooted in both global perspective and local heart, that now shapes his leadership at Courtyard Colombo.

At a recent gathering of corporate leaders, travel partners, and media friends, Suranga paid tribute to outgoing General Manager Elton Hurtis, hon oring his vision and the opportunities he created for associates to flourish across the Marriott world. With deep respect for that legacy, Suranga now steps forward to elevate guest experiences, strengthen community ties, and continue the tradition of excellence that defines Courtyard Colombo.

From his beginnings at The Lanka Oberoi and Cinnamon Grand Colombo to his leadership roles at Weligama Bay Marriott and Resplendent Ceylon, Suranga’s career is a testament to both resilience and refinement. His return to Marriott is not merely a professional milestone, it is a homecoming.

Continue Reading

Trending